Stock KHRN.H KHIRON LIFE SCIENCES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Khiron Life Sciences Corp. Share Price

Equities

KHRN.H

CA49374L3065

Pharmaceuticals

Delayed Toronto S.E.
Other stock markets
 08:24:46 05/05/2023 pm IST 		5-day change 1st Jan Change
0.04 CAD -.--% Intraday chart for Khiron Life Sciences Corp. -.--% -.--%
2023 Colombia's cannabis industry in crisis over regulatory, political hurdles RE
2023 2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp.. CI

Financials

Sales 2020 8.02 10.96 668.44 Sales 2021 12.8 17.49 1.07K Capitalization 37.61M 51.42M 3.14B
Net income 2020 -24M -32.81M -2B Net income 2021 -33M -45.11M -2.75B EV / Sales 2020 63,78,653 x
Net cash position 2020 5.38M 7.36M 449M Net cash position 2021 6.7M 9.15M 558M EV / Sales 2021 24,16,458 x
P/E ratio 2020
-1.88 x
P/E ratio 2021
-1.04 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 100%
More Fundamentals * Assessed data

Chart Khiron Life Sciences Corp.

Dynamic Chart

Latest news about Khiron Life Sciences Corp.

Colombia's cannabis industry in crisis over regulatory, political hurdles RE
2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp.. CI
2518542 Alberta Ltd agreed to acquire Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. for CAD 3 million. CI
Khiron Life Sciences Corp. Enters into Partnership with an Accredited 3rd Party Contract Manufacturing Organization CI
Khiron Life Sciences Brief: On Filing of Audited Annual Financial Statements, Co Says Won't Make It On Or Before the Prescribed Deadline of May 1, 2023, as a Result of the Change in CFO MT
Khiron Life Sciences Brief: Appointing Michael O'Connor as Chief Financial Officer, Replacing Ms. Helen Bellwood MT
Khiron Life Sciences Announces CFO Changes CI
Toronto Stocks Climb; TerrAscend Rises on Plans to Apply for TSX Listing DJ
Khiron Life Sciences Plans Overnight Marketed Offering of Share Units MT
Khiron Life Sciences Secures Additional Loan with Investment-Grade Bank MT
Khiron Life Sciences Corp. Announces That Its Wholly Owned Subsidiary Zerenia Colombia Closes an Unsecured Revolving Credit Facility of CAD 580,000 with Private Financing Company in Colombia CI
Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia MT
Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient MT
Khiron Life Sciences Corp. Announces Full Reimbursement by the NHS of Costs Associated to Cannabis-Based Medication and Clinic Fees for A Patient Enrolled in Zerenia Clinics UK CI
Khiron Wins First Medical Cannabis Contract with Colombia's Largest Public Insurance Company CI
More news

Press releases Khiron Life Sciences Corp.

Khiron Life Sciences Announces Closing of the Sale of Its European Business NE
Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business NE
IIROC Trading Halt - KHRN AQ
KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER AQ
KHIRON LIFE SCIENCES ANNOUNCES NEW CFO AQ
More press releases

News in other languages on Khiron Life Sciences Corp.

Con inversores agotados, la industria de cannabis en Colombia se marchita sin acceso a mercado y zonas grises
More news

Highs and lows

1 year
0.04
Extreme 0.04
0.05
3 years
0.04
Extreme 0.035
0.58
5 years
0.04
Extreme 0.035
3.75
10 years
0.04
Extreme 0.035
4.35
More quotes

Managers and Directors - Khiron Life Sciences Corp.

Managers TitleAgeSince
Álvaro Torres FOU
 Founder 45 16/12/16
Michael O’Connor DFI
 Director of Finance/CFO 57 17/23/17
Matthew Collins Murphy CMP
 Compliance Officer 62 -
Members of the board TitleAgeSince
Vicente Fox Quesada BRD
 Director/Board Member 81 17/18/17
Álvaro Torres FOU
 Founder 45 16/12/16
Alvaro Yañez BRD
 Director/Board Member 46 01/07/01
More insiders

Company Profile

Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
KHIRON LIFE SCIENCES CORP. Stock Khiron Life Sciences Corp.
-.--% 6.79M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+35.04% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. KHRN.H Stock